Impact of nitisinone treatment and discontinuation on the metabolome of wildtype and hereditary tyrosinemia type 1 mice

Haaike Colemonts-Vroninks; Brendan Norman; Andrew Davison; Jessie Neuckermans; Lionel Marcélis; Anneleen Mortier; Dimitri De Bundel; Lakshminarayan Ranganath; Geert Martens; Tamara Vanhaecke; James Gallagher; Joery De Kock

Impact of nitisinone treatment and discontinuation on the metabolome of wildtype and hereditary tyrosinemia type 1 mice

Haaike Colemonts-Vroninks, Brendan Norman, Andrew Davison, Jessie Neuckermans, Lionel Marcélis, Anneleen Mortier, Dimitri De Bundel, Lakshminarayan Ranganath, Geert Martens, Tamara Vanhaecke, James Gallagher, Joery De Kock

Research output: Unpublished contribution to conference › Poster

Original language	English
Pages	FRI284
Publication status	Published - 17 Apr 2020
Event	EASL 2020: The International Liver Congress - London, United Kingdom Duration: 15 Apr 2020 → 19 Apr 2020

Conference

Conference	EASL 2020
Country/Territory	United Kingdom
City	London
Period	15/04/20 → 19/04/20

EASL 2020
Haaike Colemonts-Vroninks (Member)
27 Aug 2020 → 29 Aug 2020
Activity: Participating in or organising an event › Participation in conference

Cite this

Colemonts-Vroninks, H., Norman, B., Davison, A., Neuckermans, J., Marcélis, L., Mortier, A., De Bundel, D., Ranganath, L., Martens, G., Vanhaecke, T., Gallagher, J., & De Kock, J. (2020). Impact of nitisinone treatment and discontinuation on the metabolome of wildtype and hereditary tyrosinemia type 1 mice. FRI284. Poster session presented at EASL 2020, London, United Kingdom.

Colemonts-Vroninks, Haaike ; Norman, Brendan ; Davison, Andrew ; Neuckermans, Jessie ; Marcélis, Lionel ; Mortier, Anneleen ; De Bundel, Dimitri ; Ranganath, Lakshminarayan ; Martens, Geert ; Vanhaecke, Tamara ; Gallagher, James ; De Kock, Joery. / Impact of nitisinone treatment and discontinuation on the metabolome of wildtype and hereditary tyrosinemia type 1 mice. Poster session presented at EASL 2020, London, United Kingdom.

@conference{1c92e61db80044ac87f42c970b4bf2f7,

title = "Impact of nitisinone treatment and discontinuation on the metabolome of wildtype and hereditary tyrosinemia type 1 mice",

author = "Haaike Colemonts-Vroninks and Brendan Norman and Andrew Davison and Jessie Neuckermans and Lionel Marc{\'e}lis and Anneleen Mortier and {De Bundel}, Dimitri and Lakshminarayan Ranganath and Geert Martens and Tamara Vanhaecke and James Gallagher and {De Kock}, Joery",

year = "2020",

month = apr,

day = "17",

language = "English",

pages = "FRI284",

note = "EASL 2020 : The International Liver Congress ; Conference date: 15-04-2020 Through 19-04-2020",

}

Impact of nitisinone treatment and discontinuation on the metabolome of wildtype and hereditary tyrosinemia type 1 mice. / Colemonts-Vroninks, Haaike; Norman, Brendan; Davison, Andrew; Neuckermans, Jessie; Marcélis, Lionel; Mortier, Anneleen; De Bundel, Dimitri; Ranganath, Lakshminarayan; Martens, Geert; Vanhaecke, Tamara; Gallagher, James; De Kock, Joery.

2020. FRI284 Poster session presented at EASL 2020, London, United Kingdom.

Research output: Unpublished contribution to conference › Poster

TY - CONF

T1 - Impact of nitisinone treatment and discontinuation on the metabolome of wildtype and hereditary tyrosinemia type 1 mice

AU - Colemonts-Vroninks, Haaike

AU - Norman, Brendan

AU - Davison, Andrew

AU - Neuckermans, Jessie

AU - Marcélis, Lionel

AU - Mortier, Anneleen

AU - De Bundel, Dimitri

AU - Ranganath, Lakshminarayan

AU - Martens, Geert

AU - Vanhaecke, Tamara

AU - Gallagher, James

AU - De Kock, Joery

PY - 2020/4/17

Y1 - 2020/4/17

M3 - Poster

SP - FRI284

T2 - EASL 2020

Y2 - 15 April 2020 through 19 April 2020

ER -

Impact of nitisinone treatment and discontinuation on the metabolome of wildtype and hereditary tyrosinemia type 1 mice

Conference

Activities

EASL 2020

Cite this